<p>Malignant Ovarian Tumors During Pregnancy: A Multicenter Retrospective Analysis</p>Liya Wang, Yu Wang, Shenjiao Huang et al.|Cancer Management and Research|2020Cited by 14
A phase II efficacy and safety study of HB0025 (a PD-L1/VEGF bispecific antibody) in combination with chemotherapy as first-line treatment for advanced or recurrent endometrial cancer.Ju‐Dong Li, Lee Li, Yuping Sun et al.|Journal of Clinical Oncology|2025Cited by 4